1 EDKA Precipitating Factors SGLT2i: In the United States, SGLT2i (canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin) are currently approved to treat only T2DM, not T1DM
[DOI] [PMC free article] [PubMed] [Google Scholar] 223.Mazure NM, Chen EY, Yeh P, Laderoute KR, Giaccia AJ
317 It has been shown that fatty acids strongly enhance GIP secretion, and this hormone then subsequently plays an important role in mediating fat uptake into adipose tissue
Revitalize from within
Finally, transcriptomics (e.g., liver and adipose RNA-seq) can map which metabolic programs shift during exposuredata that help explain physiological readouts without implying clinical utility
The pitch often promises fast, noticeable results with little effort and minimal risk